Research ArticleCORONAVIRUS

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

See allHide authors and affiliations

Science Translational Medicine  02 Sep 2020:
Vol. 12, Issue 559, eabc3103
DOI: 10.1126/scitranslmed.abc3103

Article Information

vol. 12 no. 559

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication April 18, 2020
  • Accepted for publication August 13, 2020
  • .

Article Versions

Author Information

  1. Ludivine Grzelak1,2,3,*,
  2. Sarah Temmam4,*,
  3. Cyril Planchais5,*,
  4. Caroline Demeret6,7,*,
  5. Laura Tondeur8,
  6. Christèle Huon4,
  7. Florence Guivel-Benhassine1,2,
  8. Isabelle Staropoli1,2,
  9. Maxime Chazal9,
  10. Jeremy Dufloo1,2,3,
  11. Delphine Planas1,2,
  12. Julian Buchrieser1,2,
  13. Maaran Michael Rajah1,2,3,
  14. Remy Robinot1,2,
  15. Françoise Porrot1,2,
  16. Mélanie Albert6,7,10,
  17. Kuang-Yu Chen11,
  18. Bernadette Crescenzo-Chaigne6,7,
  19. Flora Donati6,7,10,
  20. François Anna12,
  21. Philippe Souque13,
  22. Marion Gransagne14,
  23. Jacques Bellalou15,
  24. Mireille Nowakowski15,
  25. Marija Backovic16,
  26. Lila Bouadma17,18,
  27. Lucie Le Fevre18,
  28. Quentin Le Hingrat17,19,
  29. Diane Descamps17,19,
  30. Annabelle Pourbaix20,
  31. Cédric Laouénan17,21,
  32. Jade Ghosn17,20,
  33. Yazdan Yazdanpanah17,20,
  34. Camille Besombes8,
  35. Nathalie Jolly22,
  36. Sandrine Pellerin-Fernandes22,
  37. Olivia Cheny22,
  38. Marie-Noëlle Ungeheuer22,
  39. Guillaume Mellon23,
  40. Pascal Morel24,
  41. Simon Rolland25,26,
  42. Felix A. Rey16,
  43. Sylvie Behillil6,7,10,
  44. Vincent Enouf6,7,10,
  45. Audrey Lemaitre27,
  46. Marie-Aude Créach28,29,
  47. Stephane Petres15,
  48. Nicolas Escriou14,
  49. Pierre Charneau12,13,
  50. Arnaud Fontanet8,30,
  51. Bruno Hoen31,
  52. Timothée Bruel1,2,
  53. Marc Eloit4,32,,,
  54. Hugo Mouquet5,,
  55. Olivier Schwartz1,2,, and
  56. Sylvie van der Werf6,7,10,
  1. 1Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
  2. 2Vaccine Research Institute, Creteil, France.
  3. 3Université de Paris, Sorbonne Paris Cité, Paris, France.
  4. 4Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.
  5. 5Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France.
  6. 6Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
  7. 7Université de Paris, Paris, France.
  8. 8Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France.
  9. 9Department of Virology, Institut Pasteur, Paris, France.
  10. 10National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.
  11. 11RNA Biology of Influenza Virus, Department of Virology, Institut Pasteur, Paris, France.
  12. 12Pasteur-TheraVectys joined unit, Institut Pasteur, Paris, France.
  13. 13Molecular Virology and Vaccinology Unit, Department of Virology, Institut Pasteur, Paris, France.
  14. 14Innovation lab: Vaccines, Institut Pasteur, Paris, France.
  15. 15Plate-Forme Technologique Production et Purification de Protéines Recombinantes, Institut Pasteur, Paris, France.
  16. 16Structural Virology Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.
  17. 17Université of Paris, INSERM UMR 1137 IAME, Paris, France.
  18. 18Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, Paris, France.
  19. 19Department of Virology, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, Paris, France.
  20. 20Department of Infectious Diseases, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, Paris, France.
  21. 21Department of Epidemiology, Biostatistics and Clinical Research, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, INSERM CIC-EC 1425, Paris, France.
  22. 22Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Center for Translational Research, Institut Pasteur, Paris, France.
  23. 23Unité Coordination du Risque Epidémique et Biologique, AP-HP, Hôpital Necker, Paris, France.
  24. 24Etablissement Français du Sang (EFS), Paris, France.
  25. 25Service de maladies infectieuses, hôpital universitaire Cavale Blanche, Brest, France.
  26. 26CIC 1417, CIC de vaccinologie Cochin-Pasteur, AP-HP, Hôpital Cochin, Paris, France.
  27. 27Direction alerte et crises, réserve sanitaire, Santé publique France, Saint-Maurice, France.
  28. 28Centre d’épidémiologie et de santé publique des armées, Marseille, France.
  29. 29Direction Générale de la Santé, Paris, France.
  30. 30PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.
  31. 31Direction de la recherche médicale, Institut Pasteur, Paris, France.
  32. 32National Veterinary School of Alfort, Maisons-Alfort, France.
  1. Corresponding author. Email: marc.eloit{at}pasteur.fr (M.E.); schwartz{at}pasteur.fr (O.S.)
  • * These authors contributed equally as co-first authors.

  • These authors contributed equally as co-last authors.

Altmetric

Article usage

Article usage: August 2020 to November 2020

AbstractFullPdf
Aug 202013329091359
Sep 202029864452077
Oct 20204223481095
Nov 2020281708691

Stay Connected to Science Translational Medicine

Navigate This Article